1. Home
  2. ZETA vs PRAX Comparison

ZETA vs PRAX Comparison

Compare ZETA & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Global Holdings Corp.

ZETA

Zeta Global Holdings Corp.

N/A

Current Price

$31.02

Market Cap

8.2B

Sector

Technology

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$285.86

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZETA
PRAX
Founded
2007
2015
Country
United States
United States
Employees
3300
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ZETA
PRAX
Price
$31.02
$285.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
21
Target Price
$38.29
★ $650.00
AVG Volume (30 Days)
★ 4.9M
468.2K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.16
N/A
EPS
★ N/A
N/A
Revenue
★ $1,304,668,000.00
N/A
Revenue This Year
$39.47
N/A
Revenue Next Year
$16.12
$41,442.59
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 29.72
N/A
52 Week Low
$14.37
$154.46
52 Week High
$35.75
$392.70

Technical Indicators

Market Signals
Indicator
ZETA
PRAX
Relative Strength Index (RSI) 42.86 53.91
Support Level $30.24 $284.55
Resistance Level $32.41 $347.63
Average True Range (ATR) 1.70 12.62
MACD -0.30 6.37
Stochastic Oscillator 12.92 90.29

Price Performance

Historical Comparison
ZETA
PRAX

About ZETA Zeta Global Holdings Corp.

Zeta Global Holdings Corp is an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software. It serves enterprise customers across multiple industries, including financial services, insurance, telecommunications, automotive, travel and hospitality, and retail. Its Zeta Marketing Platform, or ZMP, is an omnichannel marketing platform with identity data at its core. The ZMP can analyze billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing. The company operates in U.S, where it generates maximum revenue and Internationally as well.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: